Latest company presentations

Discover our lead drug candidates

Enquire Now

Investor inquiries

For investor related enquiries please contact
Brad Dilkes:

Media inquiries

For press and media related enquiries please contact
Joel Latham:

Subscribe and stay connected

Stay up to date with Incannex’s leading research and development programs, multiple secondary assets, investor relations and biotechnology advancements.

"*" indicates required fields